AnalystBro Research

Research

Company valuation reports, peer comparisons, results notes, industry reports and macro views, built from company filings and official data and independently reviewed before publishing. Company reports show their full model as view-only sheets. Facts and estimates, not investment advice.

3 articles.

Company · DSE:KDSALTD · Textiles: garment trims and packaging · Analysis · 01 Nov 2026

KDS Accessories: FY2026 EPS of BDT 2.20, with interest from two group companies equal to 47% of FY2025 pre-tax profit

A Chattogram and Gazipur maker of cartons, labels, buttons and elastics for garment exporters. Cartons were 82% of FY2025 sales. Revenue grew 14% in FY2025 and fell 12% in the nine months to March 2026, while BDT 995m lent to KDS Thread and KDS Poly at 9.5% earned BDT 91.5m of interest.

Company · DSE:ACIFORMULA · Chemicals, paints & gases · Analysis · 01 Nov 2026

ACI Formulations: crop care earns the profit, paint and aerosol lose money, and BDT 2.4bn is lent to the ACI group

FY2026 consolidated EPS rose 1.4% to BDT 7.96 on a 20% dividend, but operating cash flow was negative for the year; inter-company receivables reached BDT 2.38bn in September 2025 while bank debt rose to BDT 4.36bn.

Company · DSE:JHRML · Pharmaceuticals & healthcare (medical devices) · Analysis · 31 Oct 2026

JMI Hospital Requisite: device sales fell 10.7% in FY2025 and a new hospital cut FY2026 EPS to BDT 0.71; BDT 745m is lent to sister companies

Revenue fell from BDT 1,870m to 1,671m in FY2025 and 9M FY2026 sales were 6.1% lower again; the Apollo-licensed hospital opened in August 2025 and lost about BDT 81m in nine months. Interest charged to group companies was 30% of FY2025 pre-tax profit.